Cetera Investment Advisers
IDXX icon

Cetera Investment Advisers’s Idexx Laboratories IDXX Stock Holding History

Cetera Investment Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.2K Buy
+200
New +$112K ﹤0.01% 4912

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cetera Investment Advisers's IDXX Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Idexx Laboratories (IDXX) stake by 5.1% in Q2 2026, selling an estimated $692K and leaving 22,840 shares worth $12M. The position accounts for 0.01% of the portfolio, ranked #1038.

Cetera Investment Advisers first reported a position in IDXX in Q4 2020 and has held it in 23 quarters since. The position peaked at $16.8M in Q4 2025. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cetera Investment Advisers held 22,840 shares of Idexx Laboratories worth $12M as of Q2 2026.
  • Cetera Investment Advisers sold 1,233 Idexx Laboratories shares in Q2 2026, an estimated $692K.
  • Idexx Laboratories made up 0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #1038 holding.
  • Cetera Investment Advisers first reported a position in Idexx Laboratories in Q4 2020 and has held it in 23 quarters since.
  • Cetera Investment Advisers's Idexx Laboratories position peaked at $16.8M in Q4 2025.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.